Neurocrine Biosciences (NBIX) FCF Margin (2010 - 2026)
Neurocrine Biosciences (NBIX) posted FCF Margin of 13.41% for Q2 2026, up 0.39 percentage points from 13.02% a year earlier but down 3.37 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) FCF Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Neurocrine Biosciences was 25.80%, up 4.73 percentage points year-over-year; for FY2025, it came in at 26.17%, up 2.52 percentage points from FY2024.
- Annual FCF Margin shows a five-year change of +5.37 percentage points (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' FCF Margin was 23.66% in FY2024 (+4.50 pp), 19.16% in FY2023 (-2.53 pp), 21.69% in FY2022 (+1.13 pp) and 20.56% in FY2021 (-0.24 pp).
- Quarterly FCF Margin has run from a low of -31.80% in Q1 2023 to a high of 48.52% in Q4 2025 over five years.
- On a year-over-year basis, FCF Margin has increased in each of the last five quarters, with an average year-over-year change of +1.21 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2024, with a gain of 54.92 percentage points; the weakest was Q1 2022, with a drop of 50.48 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was 16.78% (Q1 2026), 48.52% (Q4 2025) and 26.96% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Neurocrine Biosciences | 14.06 Bn | 9.76 Bn | 935.80 Mn | 13.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.41% |
| Mar 31, 2026 | 16.78% |
| Dec 31, 2025 | 48.52% |
| Sep 30, 2025 | 26.96% |
| Jun 30, 2025 | 13.02% |
| Mar 31, 2025 | 9.45% |
| Dec 31, 2024 | 37.47% |
| Sep 30, 2024 | 24.10% |
| Jun 30, 2024 | 8.98% |
| Mar 31, 2024 | 23.11% |
| Dec 31, 2023 | 22.92% |
| Sep 30, 2023 | 40.98% |
| Jun 30, 2023 | 38.17% |
| Mar 31, 2023 | -31.80% |
| Dec 31, 2022 | 34.27% |
| Sep 30, 2022 | 25.91% |
| Jun 30, 2022 | 34.19% |
| Mar 31, 2022 | -15.49% |
| Dec 31, 2021 | -1.51% |
| Sep 30, 2021 | 18.95% |
API Access
Neurocrine Biosciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();